"„МБАЛ Св. Панталеймон – Плевен” ООД разполага с водещата в централна и северна България Клиника по ортопедия и травматология. В нея се извършват гръбначна хирургия, артроскопска хирургия и детска ортопедия. Болницата има договор със Здравната каса и работи по клинични пътеки. Пациентите могат да избират ВИП условия (самостоятелна стая и консумативи) срещу допълнително заплащане."

During the past decade, DCC 'Sv. Pantaleymon' OOD conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "DCC 'Sv. Pantaleymon' OOD" #1 sponsor was "R-Pharm International, LLC" with 2 trials, followed by "Hoffmann-La Roche" with 1 trials sponsored, "Pfizer" with 1 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored and "Takeda" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "DCC 'Sv. Pantaleymon' OOD" #1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator, "Mene Research" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "DCC 'Sv. Pantaleymon' OOD" are "Rheumatoid Arthritis" (2 trials), "Gastroesophageal Reflux" (1 trials), "Osteoarthritis, Hip" (1 trials), "Osteoarthritis, Knee" (1 trials) and "Post Herpetic Neuralgia" (1 trials). Many other conditions were trialed in "DCC 'Sv. Pantaleymon' OOD" in a lesser frequency.

Most popular intervention types in "DCC 'Sv. Pantaleymon' OOD" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Adalimumab" (1 trials), "Adalimumab Placebo" (1 trials), "Concomitant treatment" (1 trials) and "Esomeprazole" (1 trials). Other intervention names were less common.

The vast majority of trials in "DCC 'Sv. Pantaleymon' OOD" are 6 trials for "All" genders.

Currently, there are NaN active trials in "DCC 'Sv. Pantaleymon' OOD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in DCC 'Sv. Pantaleymon' OOD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in DCC 'Sv. Pantaleymon' OOD, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".